|
CN112121116A
|
|
Natural plant active factor antibacterial atomizing agent and preparation method thereof
|
|
CN112156089A
|
|
Application of benzbromarone in resisting mycobacterium tuberculosis infection
|
|
CN111755099A
|
|
A functional food composition method based on medicinal and edible Chinese medicinal materials for preventing or relieving related diseases
|
|
CN111249319A
|
|
Phospholipid complex of Eurycoma longifolia extract and preparation method thereof
|
|
CN111166866A
|
|
Potential application of bacitracin zinc in resisting mycobacterial infection
|
|
CN111150733A
|
|
Potential application of cetylpyridinium chloride in resisting mycobacterial infection
|
|
CN111150725A
|
|
Potential application of closantel sodium in resisting mycobacterium infection
|
|
CN110787164A
|
|
Application of octenidine in inhibiting acetyl transferase and resisting mycobacterial infection
|
|
CN110419596A
|
|
A kind of preparation method and application of spine date seed oil microcapsules and oral solid formulation
|
|
CN110272373A
|
|
A kind of selective adenosine A1Receptor antagonist and its application
|
|
CN110256422A
|
|
A kind of synthetic method of mannosidase inhibitor Kifunensine
|
|
CN110327342A
|
|
Application of the Tonzonium Bromide in Killing Mycobacterium Tuberculosis infection
|
|
CN110123802A
|
|
Application using Acetylshikonin as several traditional Chinese medicine monomers of representative in the infection of anti-enterovirus D68 type
|
|
CN110396086A
|
|
NO donor class compound, composition, preparation method and and its application
|
|
CN110156735A
|
|
Formononetin derivative and its preparation method and application
|
|
CN110272337A
|
|
6-gingerol derivative and its preparation and application
|
|
CN110075095A
|
|
Application of the 1,4- naphthoquinones in Killing Mycobacterium Tuberculosis infection
|
|
CN110179775A
|
|
Application of the crystal violet in Killing Mycobacterium Tuberculosis infection
|
|
CN109811030A
|
|
Application of the antazoline hydrochloride derivative as HBV inhibitor
|
|
CN109700802A
|
|
Byak-angelicin is in preparation for treating the application in pulmonary fibrosis disease drug
|
